Barinthus Biotherapeutics PLBRNS
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 14 institutions reported holding Barinthus Biotherapeutics PL (BRNS) in their 13F filings, up 1 from Q4 2025. 1 opened new positions and 1 sold out. The largest holders were M&G PLC ($5.2M), HSG Holding Ltd ($1.2M) and GLR Partners, LLC ($707K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Barinthus Biotherapeutics PL
- CUSIP
- 91864C107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $42K |
| Exits | 1 | $2K |
All 13F filers, Q4 2025 → Q1 2026: 156,331 shares bought and 4,348 shares sold, net +151,983 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| M&G PLC | 0.03% | No change | 5,197,349 | $5.2M |
| HSG Holding Ltd | 0.07% | No change | 1,420,473 | $1.2M |
| GLR Partners, LLC | 0.39% | — | 1,243,377 | $707K |
| DC Funds, LP | 24.59% | No change | 642,204 | $365K |
| Rangeley Capital, LLC | 0.10% | Add +88.8% | 159,465 | $91K |
| Renaissance Technologies | 0.00% | Add +5.5% | 151,000 | $86K |
| Johns Hopkins University | 0.01% | No change | 122,237 | $70K |
| Citadel Advisors | 0.00% | Add +0.2% | 118,996 | $68K |
| Baird Financial Group, Inc. | 0.00% | No change | 105,961 | $60K |
| GTS Securities LLC | 0.00% | New | 73,210 | $42K |
| HighTower Advisors, LLC | 0.00% | No change | 37,450 | $21K |
| Rhumbline Advisers | 0.00% | No change | 11,685 | $7K |
| Geode Capital Management, LLC | 0.00% | No change | 11,568 | $7K |
| Morgan Stanley | 0.00% | Reduce -35.1% | 2,210 | $1K |
"% of holder's portfolio" is BRNS's weight in each manager's 13F, not the share of Barinthus Biotherapeutics PL the manager owns.